Defiance Daily Target 2X Long LMND ETF LMNX
9.16 USD +0.01 (+0.09%)
At closeAug 27, 2026, 4:00 PM EDT
13.71 +4.55 +49.71%
After hours · Aug 27, 4:00 PM ET
9.16 Day range 9.96
6.90 52-week range 55.00
- YTD
- -69.19%
- 1 year
- -43.88%
- Market cap
- 1.10M
- YTD return
- -69.19%
- 1-year return
- -43.88%
- Volume
- 16.61K
- Avg volume
- 52.22K
- Open
- 9.21
- Previous close
- 9.15
- Day's range
- 9.16 – 9.96
- 52-week range
- 6.90 – 55.00
- Earnings date
- Aug 3, 2021
No chart data for this range yet.
Next earnings
Aug 3, 2021
Expected Aug 3, 2021. Consensus EPS estimate 0.21.
Financials — quick view
LMNX Revenue — quarterly 110.69M
LMNX Net income — quarterly 8.90M
LMNX EPS — quarterly 0.19
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 3, 2021 | Jun 1, 2021 | 0.21 | — | — | — |
| May 5, 2021 | Mar 1, 2021 | 0.15 | — | — | — |
| Feb 8, 2021 | Dec 1, 2020 | 0.14 | — | — | — |
| Nov 5, 2020 | Sep 1, 2020 | 0.21 | — | — | — |
| Aug 4, 2020 | Jun 1, 2020 | 0.08 | — | — | — |
| May 4, 2020 | Mar 1, 2020 | 0.04 | — | — | — |
News
AdaptHealth Appoints Harriss Currie as Chief Financial Officer 
Defiance ETFs Announces Closure of Select Funds 
Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG) 
Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Critical Comparison 
Financial Contrast: Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) vs. Minerva Surgical (NASDAQ:UTRS) 
5 Best-Performing Leveraged ETFs of Last Week 
Best-Performing Leveraged ETFs of Last Week 
Defiance Doubles Down On Lemonade With New 2X ETF For Bold Traders 
Defiance Launches LMNX: The First 2X Long ETF for Lemonade, Inc. 
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021
Your note
Sign in to keep a note on LMNX — it syncs with the Stock Master app.